Replies to post #198049 on Avid Bioservices Inc (CDMO)

[md1225]

Good article. Thank you, combination is the key to a cure. 2015 the talk will be ALL about combo XYZ plus bavituximab!

[BioBS2012]

Article: Good-bye chemo, hello immunotherapy

Stupid title, if I may say so. Haven't read the article yet, but the title points towards a bias towards immuno-oncology.
Well we know from the NSCLC and other trials of PPHM that some chemoagents would be just as vital as check-point inhibitors. Key will be understanding which combo's work best with what.

Cheers.